Jpmorgan Chase & CO Ac Immune Sa Transaction History

Jpmorgan Chase & CO

$1.22 Trillion
Q3 2024

A detailed history of Jpmorgan Chase & CO transactions in Ac Immune Sa stock. As of the latest transaction made, Jpmorgan Chase & CO holds 10,696 shares of ACIU stock, worth $29,200. This represents 0.0% of its overall portfolio holdings.

Number of Shares

10,696

Previous 11,352 5.78%

Holding current value

$29,200

Previous $45,000 11.11%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Dec 26, 2024	SELL	$2.99 - $4.2 $1,961 - $2,755	-656 Reduced 5.78%	10,696 $40,000
Q3 2024 Nov 08, 2024	SELL	$2.99 - $4.2 $1,961 - $2,755	-656 Reduced 5.78%	10,696 $40,000
Q2 2024 Dec 26, 2024	BUY	$2.29 - $4.87 $1,502 - $3,194	656 Added 6.13%	11,352 $45,000
Q2 2024 Aug 12, 2024	SELL	$2.29 - $4.87 $24,647 - $52,415	-10,763 Reduced 48.67%	11,352 $45,000
Q1 2024 Dec 26, 2024	BUY	$2.66 - $4.87 $30,374 - $55,610	11,419 Added 106.76%	22,115 $65,000
Q1 2024 May 10, 2024	BUY	$2.66 - $4.87 $47,446 - $86,866	17,837 Added 416.95%	22,115 $65,000
Q4 2023 Dec 26, 2024	SELL	$2.46 - $5.0 $15,788 - $32,090	-6,418 Reduced 60.0%	4,278 $21,000
Q4 2023 Feb 12, 2024	BUY	$2.46 - $5.0 $7,571 - $15,390	3,078 Added 256.5%	4,278 $21,000
Q3 2023 Nov 14, 2023	SELL	$2.77 - $3.38 $4,243 - $5,178	-1,532 Reduced 56.08%	1,200 $3,000
Q4 2022 Feb 13, 2023	SELL	$1.72 - $3.12 $4,367 - $7,921	-2,539 Reduced 48.17%	2,732 $6,000
Q3 2022 Nov 14, 2022	BUY	$2.4 - $3.64 $4,221 - $6,402	1,759 Added 50.09%	5,271 $17,000
Q2 2022 Aug 11, 2022	SELL	$2.35 - $4.47 $13,907 - $26,453	-5,918 Reduced 62.76%	3,512 $13,000
Q1 2022 May 11, 2022	BUY	$3.5 - $5.16 $8,393 - $12,373	2,398 Added 34.1%	9,430 $38,000
Q4 2021 Feb 10, 2022	SELL	$4.83 - $7.56 $43,948 - $68,788	-9,099 Reduced 56.41%	7,032 $35,000
Q3 2021 Nov 12, 2021	BUY	$6.2 - $8.34 $100,012 - $134,532	16,131 New	16,131 $109,000

Others Institutions Holding ACIU

# of Institutions

Shares Held

27.9M

Call Options Held

150K

Put Options Held

12.4K

View Full List

About AC Immune SA

Ticker ACIU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,413,504
Market Cap $228M
Description
AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding. Its SupraAntigen and Morphomer platforms are designed to generate vaccines, antibodies, and small molecules, which selectiv...

More about ACIU

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Ac Immune Sa Transaction History